Historical record - last NADAC effective date: 12/21/2022
Product Information
POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Adare Pharmaceuticals Inc, priced at $0.1333 per EA under NDC 59917010201. Its NADAC has been published 244 times since Apr 25, 2018.
FDA first approved this application on Mar 17, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Adare Pharmaceuticals IncNDC
59917010201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
12/21/2022
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208864FDA Approved
3/17/2017
TE Code
AB
On Market Since
4/1/2018
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 244 times since Apr 25, 2018, and over the history we have for it it has declined 58.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1333 per EA |
|---|---|
| All-time high | $0.4054 (Apr 10, 2019) |
| All-time low | $0.1169 (Nov 23, 2022) |
| Median price | $0.2686 |
| Average price | $0.2684 |
| Largest weekly change | -44.0% (Nov 23, 2022) |
| Weeks tracked | 244 |
| Tracking since | Apr 25, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-56.5%
All
-58.4%
Last surveyed Dec 21, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Adare Pharmaceuticals Inc, is $0.1333 per EA (NDC 59917010201), effective Dec 21, 2022.
How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 58.4%. It has been tracked across 244 weekly CMS publications since Apr 25, 2018.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?
Since Apr 25, 2018, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.1169 (Nov 23, 2022) to a high of $0.4054 (Apr 10, 2019), with a median of $0.2686 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 8 MEQ CAPSULE, is $0.0936 per EA — about 30% below POTASSIUM CL ER 8 MEQ CAPSULE.
Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?
POTASSIUM CL ER 8 MEQ CAPSULE (NDC 59917010201) is labeled by Adare Pharmaceuticals Inc, and CMS classifies it as a generic product.